HOLA® - Hysteroscopic Outpatient Laser Applications

 
HOLA® is an acronym and stands for "Hysteroscopic Outpatient Laser Applications". HOLA® covers all applications in hysteroscopy: 

  • myomas
  • adenoids
  • septum
  • isthmocele

Worldwide, approximately one third of women above the age of 30 are affected by myomas. biolitec® offers a laser therapy that has significantly fewer complications and side effects than previous treatment methods. Hysterectomy as a standard method does not only carry with it the loss of the ability to bear children and a sometimes heavy psychological burden, but can also lead to the early onset of menopause. The minimally invasive treatment of myomas which maintains the uterus is therefore not only of great importance for women who want to have children.

The benefits of HOLA® are: The laser energy used avoids constricting the muscle tissue and can be used either with or without minimal local anaesthetic. The enucleation with the laser fiber in contact mode leads to precise control of the laser energy and therefore a controlled cut. The coagulation that occurs in parallel ensures that the work is done without haemorrhaging. Continuous cleaning during the entire operation allows for the safe use of laser energy with constantly good visibility.
 

Upcoming Events:

16.11.-19.11.2020 Medica 2020, Hall 10 Booth H46
in Dusseldorf, Germany

05.12.-08.12.2020

Postponed to 08.05.-11.05. 2021

Endometriosis 2020
in Rome, Italy
13.02.2021

Laser Safety Course biolitec
Speaker: Dr. Roland Dreschau, CeramOptec GmbH
Attendance fee: € 295,- zzgl. MwSt.
Event location: biolitec biomedical technology GmbH, Brühler Str. 30, 53119 Bonn
Registration: iris.walterscheid@biolitec.com

08.05.-11.05. 2021

Postponed from 05.12.-08.12.2020

Endometriosis 2021
in Rome, Italy